Literature DB >> 6382836

Hematologic and oncologic complications in the critically ill child.

S McIntosh.   

Abstract

Admission of a patient to an intensive care unit for management of direct consequences of a hematologic or oncologic disease is occasionally necessary. Such problems included exchange transfusion, sepsis, compression of vital structures by malignant tumor, metabolic derangements, leukostasis, post-operative care, major sickling episodes in vital organs, and disseminated coagulopathy. More often, however, hematologic complications arise in the child critically ill from other causes, such as trauma or infections. The first two sections of this review address blood transfusion and hemostasis, topics likely to have wide application in the care of critically ill children. The last portion discusses problems unique to patients with sickling or malignant disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6382836      PMCID: PMC2589801     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  275 in total

1.  A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time.

Authors:  D Basu; A Gallus; J Hirsh; J Cade
Journal:  N Engl J Med       Date:  1972-08-17       Impact factor: 91.245

2.  Interactions of other hemoglobin variants with sickle-cell hemoglobin.

Authors:  H M Ranney
Journal:  N Engl J Med       Date:  1970-12-24       Impact factor: 91.245

Review 3.  Pathogenesis and management of hemolytic transfusion reactions.

Authors:  T J Greenwalt
Journal:  Semin Hematol       Date:  1981-04       Impact factor: 3.851

4.  Intracranial calcifications in childhood leukemia. An association with systemic chemotherapy.

Authors:  S McIntosh; D B Fischer; S G Rothman; N Rosenfield; J S Lobel; R O'Brien
Journal:  J Pediatr       Date:  1977-12       Impact factor: 4.406

Review 5.  Diagnosis and management of disseminated intravascular coagulation: the role of heparin therapy.

Authors:  D I Feinstein
Journal:  Blood       Date:  1982-08       Impact factor: 22.113

Review 6.  The development of hemostasis in the human fetus and newborn infant.

Authors:  W A Bleyer; N Hakami; T H Shepard
Journal:  J Pediatr       Date:  1971-11       Impact factor: 4.406

Review 7.  Nonhemolytic, noninfectious transfusion reactions.

Authors:  J C Barton
Journal:  Semin Hematol       Date:  1981-04       Impact factor: 3.851

8.  The use of prophylactic partial exchange tranfusion in pregnancies associated with sickle cell hemoglobinopathies.

Authors:  J C Morrison; W L Wiser
Journal:  Obstet Gynecol       Date:  1976-11       Impact factor: 7.661

9.  RBC destruction caused by a micropore blood filter.

Authors:  W F Schmidt; H C Kim; N Tomassini; E Schwartz
Journal:  JAMA       Date:  1982-10-01       Impact factor: 56.272

10.  Staphylococcus aureus sepsis in children with cancer.

Authors:  S Ladisch; P A Pizzo
Journal:  Pediatrics       Date:  1978-02       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.